This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Albert, A., “Selective Toxicity” (Methuen, London, 1951). (Second edition in the press.)
Albert, A., Ergebnisse der Physiol., 49, 425 (1957).
Veldstra, H., Pharmacol. Rev., 8, 339 (1956).
Brodie, B. B., Science, 121, 603 (1955).
Brodie, B. B., and Hogben, C. A., J. Pharm. Pharmacol., 9, 345 (1957).
Davson, H., and Danielli, J., “The Permeability of Natural Membranes” (Cambridge University Press, 1952).
Ehrlich, P., Berl. Klin. Woschr., 682 (1900).
Ehrlich, P., letter to Carl Weigert (1898) in Ehrlich's Collected Papers (Wellcome Trust, London, 1958).
Pauling, L., in Landsteiner, K., “Specificity of Serological Reactions”, 276 (Harvard University Press, 1946).
Woods, D. D., Brit. J. Exper. Path., 21, 74 (1940).
Albert, A., Rubbo, S., Goldacre, R., Davey, M., and Stone, J., Brit. J. Exper. Path., 26, 160 (1945).
Albert, A., Rubbo, S., Goldacre, R., and Balfour, B., Brit. J. Exper. Path., 28, 69 (1947).
Albert, A., Gibson, M., and Rubbo, S., Brit. J. Exper. Path., 34, 119 (1953).
Woolley, D. W., “A Study of Antimetabolites” (Wiley, New York, 1952).
Hitchings, G. H., Trans. Roy. Soc. Trop. Med. Lond., 46, 467 (1952).
Albert, A., Pharmacol. Rev., 4, 136 (1952).
Albert, A., in “The Strategy of Chemotherapy” (Cambridge University Press, 1958).
Newton, B. A., in “The Strategy of Chemotherapy” (Cambridge University Press, 1958).
Cullen, S. C., and Gross, E. G., Science, 113, 580 (1951).
Ferguson, J., Proc. Roy. Soc., B, 127, 387 (1939).
Ferguson, J., Colloques Internationaux du Centre Nationale de la Recherche Scientifique, No. 26, 25 (1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ALBERT, A. Chemical Aspects of Selective Toxicity. Nature 182, 421–423 (1958). https://doi.org/10.1038/182421a0
Issue Date:
DOI: https://doi.org/10.1038/182421a0
This article is cited by
-
Synthesis of doxorubicin pro-drug nanoparticles based on poloxamer188 and studies on their in vivo bio-security and in vitro anti-tumor activities
Iranian Polymer Journal (2024)
-
Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery
Journal of Nanobiotechnology (2022)
-
Phosphoryl prodrugs: characteristics to improve drug development
Medicinal Chemistry Research (2022)
-
Prodrugs as drug delivery system in oncology
Cancer Chemotherapy and Pharmacology (2019)
-
Prospects for Intranasal Delivery of Neuropeptides to the Brain
Pharmaceutical Chemistry Journal (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.